How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the unique challenges faced by our industry. The Senior BioPhorum Connect group – consisting of the le...
Development Group trends and new hot topics
Driven by the ever-increasing need to reduce product development lead times and the opportunities to exploit new technol...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
Microchip electrophoresis and novel excipients: learnings and opportunities
Development Group’s (DG) mission focuses on better and faster process development of biopharmaceutical medicines....
Start your procurement journey with the right approach to knowledge management
Many IT systems allow information capture, storage and retrieval. And with the advent of advanced analytics and ‘big d...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
New ideas on forced degradation studies
Forced degradation studies (FDS) are a crucial part of the drug lifecycle process because companies need to fully unders...
PAT Monitoring and Control
The PAT Monitoring and Control Workstream mobilized in May 2018 and has representation from 23 member companies. Their m...
The BioPhorum and USP collaborative journey to new standards
BioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality ...
Perfecting balanced scorecards for CDMOs
The Development Group’s Development Outsourcing effort aims to share and build guidance that will help companies make ...
Formulation team drive for more value
Since its start in 2013, the Formulation Point Share has been busy. Its latest article, An inter-company perspective on ...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Development Group trends and new hot topics
Driven by the ever-increasing need to reduce product development lead times and the opportunities to exploit new technol...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
Microchip electrophoresis and novel excipients: learnings and opportunities
Development Group’s (DG) mission focuses on better and faster process development of biopharmaceutical medicines....
Start your procurement journey with the right approach to knowledge management
Many IT systems allow information capture, storage and retrieval. And with the advent of advanced analytics and ‘big d...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
New ideas on forced degradation studies
Forced degradation studies (FDS) are a crucial part of the drug lifecycle process because companies need to fully unders...
PAT Monitoring and Control
The PAT Monitoring and Control Workstream mobilized in May 2018 and has representation from 23 member companies. Their m...
The BioPhorum and USP collaborative journey to new standards
BioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality ...
Perfecting balanced scorecards for CDMOs
The Development Group’s Development Outsourcing effort aims to share and build guidance that will help companies make ...
